Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

Mohamed A. Kharfan-Dabaja, Michael D. Jain, Sonikpreet Aulakh, Ernesto Ayala, Abba Zubair, Han W Tun, Hien D. Liu, Frederick L. Locke, Julio C. Chavez

Research output: Contribution to journalLetter

Original languageEnglish (US)
JournalAmerican journal of hematology
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Hematology

Cite this